Fritsch Jürgen, Fickers Ricarda, Klawitter Jan, Särchen Vinzenz, Zingler Philipp, Adam Dieter, Janssen Ottmar, Krause Eberhard, Schütze Stefan
Institute of Immunology, Christian-Albrechts-University of Kiel, Kiel, Germany.
Leibniz Institute for Molecular Pharmacology, Berlin, Germany.
Oncotarget. 2016 Nov 15;7(46):75774-75789. doi: 10.18632/oncotarget.12411.
During apoptosis induction by TNF, the extrinsic and intrinsic apoptosis pathways converge at the lysosomal-mitochondrial interface. Earlier studies showed that the lysosomal aspartic protease Cathepsin D (CtsD) cleaves Bid to tBid, resulting in the amplification of the initial apoptotic cascade via mitochondrial outer membrane permeabilization (MOMP).The goal of this study was to identify further targets for CtsD that might be involved in activation upon death receptor ligation. Using a proteomics screen, we identified the heat shock protein 90 (HSP90) to be cleaved by CtsD after stimulation of U937 or other cell lines with TNF, FasL and TRAIL. HSP90 cleavage corresponded to apoptosis sensitivity of the cell lines to the different stimuli. After mutation of the cleavage site, HSP90 partially prevented apoptosis induction in U937 and Jurkat cells. Overexpression of the cleavage fragments in U937 and Jurkat cells showed no effect on apoptosis, excluding a direct pro-apoptotic function of these fragments. Pharmacological inhibition of HSP90 with 17AAG boosted ligand mediated apoptosis by enhancing Bid cleavage and caspase-9 activation. Together, we demonstrated that HSP90 plays an anti-apoptotic role in death receptor signalling and that CtsD-mediated cleavage of HSP90 sensitizes cells for apoptosis. These findings identify HSP90 as a potential target for cancer therapy in combination with death ligands (e.g. TNF or TRAIL).
在肿瘤坏死因子(TNF)诱导细胞凋亡的过程中,外源性和内源性凋亡途径在溶酶体 - 线粒体界面处交汇。早期研究表明,溶酶体天冬氨酸蛋白酶组织蛋白酶D(CtsD)可将Bid切割成tBid,从而通过线粒体外膜通透性改变(MOMP)导致初始凋亡级联反应的放大。本研究的目的是进一步确定CtsD的其他靶点,这些靶点可能参与死亡受体连接后的激活过程。通过蛋白质组学筛选,我们发现用TNF、FasL和TRAIL刺激U937或其他细胞系后,热休克蛋白90(HSP90)会被CtsD切割。HSP90的切割与细胞系对不同刺激的凋亡敏感性相对应。切割位点突变后,HSP90可部分阻止U937和Jurkat细胞的凋亡诱导。在U937和Jurkat细胞中过表达切割片段对凋亡没有影响,排除了这些片段的直接促凋亡功能。用17AAG对HSP90进行药理学抑制可通过增强Bid切割和半胱天冬酶 - 9激活来促进配体介导的凋亡。我们共同证明,HSP90在死亡受体信号传导中发挥抗凋亡作用,并且CtsD介导的HSP90切割使细胞对凋亡敏感。这些发现确定HSP90是与死亡配体(如TNF或TRAIL)联合用于癌症治疗的潜在靶点。